Fluicell (Sweden) Today
| FLUI Stock | SEK 0.11 0.01 8.33% |
Performance0 of 100
| Odds Of DistressOver 67
|
Fluicell is selling for under 0.11 as of the 17th of April 2024; that is -8.33 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.1. Fluicell has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Fluicell AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of July 2023 and ending today, the 17th of April 2024. Click here to learn more.
Fluicell AB provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company was founded in 2012 and is based in Gothenburg, Sweden. Fluicell operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 24.49 M outstanding shares. More on Fluicell AB
Moving together with Fluicell Stock
| 0.87 | GENO | Genovis AB | PairCorr |
| 0.65 | HNSA | Hansa Biopharma AB Earnings Call Tomorrow | PairCorr |
Moving against Fluicell Stock
| 0.91 | ATCO-A | Atlas Copco AB Earnings Call This Week | PairCorr |
| 0.88 | ATCO-B | Atlas Copco AB | PairCorr |
| 0.87 | SWED-A | Swedbank AB Earnings Call Next Week | PairCorr |
| 0.86 | INVE-A | Investor AB ser | PairCorr |
| 0.86 | INVE-B | Investor AB ser | PairCorr |
| 0.85 | XSPRAY | XSpray Pharma AB | PairCorr |
| 0.85 | LIAB | Lindab International | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Fluicell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fluicell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fluicell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Fluicell AB (FLUI) is traded on Stockholm Exchange in Sweden and employs 19 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fluicell's market, we take the total number of its shares issued and multiply it by Fluicell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fluicell AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 24.49 M outstanding shares.
Fluicell AB has accumulated about 20.69 M in cash with (18.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Fluicell Probability Of Bankruptcy
Ownership AllocationFluicell AB retains a total of 24.49 Million outstanding shares. Fluicell AB shows 11.2 percent of its outstanding shares held by insiders and 0.67 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Fluicell Ownership Details
Fluicell Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Fluicell jumping above the current price in 90 days from now is about 80.23%. The Fluicell AB probability density function shows the probability of Fluicell stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.4776. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Fluicell will likely underperform. Additionally, fluicell AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Fluicell to move above the current price in 90 days from now is about 80.23 (This Fluicell AB probability density function shows the probability of Fluicell Stock to fall within a particular range of prices over 90 days) .
Fluicell AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Fluicell market risk premium is the additional return an investor will receive from holding Fluicell long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Fluicell. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Fluicell's alpha and beta are two of the key measurements used to evaluate Fluicell's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 8.49 | |||
| Standard Deviation | 15.04 | |||
| Variance | 226.09 | |||
| Risk Adjusted Performance | (0.04) |
Fluicell Stock Against Markets
Picking the right benchmark for Fluicell stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Fluicell stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Fluicell is critical whether you are bullish or bearish towards Fluicell AB at a given time. Please also check how Fluicell's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fluicell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Fluicell Corporate Management
Elected by the shareholders, the Fluicell's board of directors comprises two types of representatives: Fluicell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fluicell. The board's role is to monitor Fluicell's management team and ensure that shareholders' interests are well served. Fluicell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fluicell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matija Rojnik | Chief Officer | Profile | |
| Tatsiana Lobovkina | Chief Officer | Profile | |
| Mats Jonasson | Chief Officer | Profile | |
| Victoire Viannay | Chief Officer | Profile | |
| Jonas Hannestad | Chief Officer | Profile | |
| Gavin Jeffries | CTO Director | Profile |
How to buy Fluicell Stock?
Before investing in Fluicell, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Fluicell. To buy Fluicell stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Fluicell. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Fluicell stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Fluicell AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Fluicell AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Fluicell AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Fluicell AB?
The danger of trading Fluicell AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Fluicell is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Fluicell. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Fluicell AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fluicell AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Fluicell Stock analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets |